EU approves endometrial, lung cancer drugs from GSK and J&J
Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
The changing landscape of journal performance measurement
In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the
In conversation at Veeva Summit: Jonathan Crowther, Pfizer
At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s head of predictive analytics, Jonathan Crowther, to discuss the ro
5 strategies to retain top talent
The pharma sales industry is in the midst of rapid transformation, fuelled by digital disruption and dynamic market forces.
Datapharm partners with phactMI to enhance medicines informa...
Datapharm, a leading medicines information solution provider in Europe, is delighted to announce its expansion into the United States (US) through a new partnership with the Pharma Collabor
4th ADC Analytical Development Summit
The 4th ADC Analytical Development Summit focuses on refining analytical techniques to meet the increasing regulatory demands and product complex